These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 21144578)

  • 1. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.
    Rothwell PM; Fowkes FG; Belch JF; Ogawa H; Warlow CP; Meade TW
    Lancet; 2011 Jan; 377(9759):31-41. PubMed ID: 21144578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.
    Rothwell PM; Wilson M; Price JF; Belch JF; Meade TW; Mehta Z
    Lancet; 2012 Apr; 379(9826):1591-601. PubMed ID: 22440947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
    Rothwell PM; Wilson M; Elwin CE; Norrving B; Algra A; Warlow CP; Meade TW
    Lancet; 2010 Nov; 376(9754):1741-50. PubMed ID: 20970847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.
    Rothwell PM; Price JF; Fowkes FG; Zanchetti A; Roncaglioni MC; Tognoni G; Lee R; Belch JF; Wilson M; Mehta Z; Meade TW
    Lancet; 2012 Apr; 379(9826):1602-12. PubMed ID: 22440946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
    Algra AM; Rothwell PM
    Lancet Oncol; 2012 May; 13(5):518-27. PubMed ID: 22440112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
    Flossmann E; Rothwell PM;
    Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
    Rothwell PM; Cook NR; Gaziano JM; Price JF; Belch JFF; Roncaglioni MC; Morimoto T; Mehta Z
    Lancet; 2018 Aug; 392(10145):387-399. PubMed ID: 30017552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.
    Cook NR; Lee IM; Zhang SM; Moorthy MV; Buring JE
    Ann Intern Med; 2013 Jul; 159(2):77-85. PubMed ID: 23856681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
    Joharatnam-Hogan N; Cafferty F; Hubner R; Swinson D; Sothi S; Gupta K; Falk S; Patel K; Warner N; Kunene V; Rowley S; Khabra K; Underwood T; Jankowski J; Bridgewater J; Crossley A; Henson V; Berkman L; Gilbert D; Kynaston H; Ring A; Cameron D; Din F; Graham J; Iveson T; Adams R; Thomas A; Wilson R; Pramesh CS; Langley R;
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):854-862. PubMed ID: 31477558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.
    Chen ZM; Sandercock P; Pan HC; Counsell C; Collins R; Liu LS; Xie JX; Warlow C; Peto R
    Stroke; 2000 Jun; 31(6):1240-9. PubMed ID: 10835439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin and cancer mortality: a meta-analysis of randomized trials.
    Mills EJ; Wu P; Alberton M; Kanters S; Lanas A; Lester R
    Am J Med; 2012 Jun; 125(6):560-7. PubMed ID: 22513195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancers prevented in Australia in 2010 through the consumption of aspirin.
    Wilson LF; Green AC; Kendall BJ; Jordan SJ; Nagle CM; Bain CJ; Neale RE; Whiteman DC
    Aust N Z J Public Health; 2015 Oct; 39(5):414-7. PubMed ID: 26437724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
    Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
    Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
    Cook NR; Lee IM; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
    JAMA; 2005 Jul; 294(1):47-55. PubMed ID: 15998890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women.
    van Kruijsdijk RC; Visseren FL; Ridker PM; Dorresteijn JA; Buring JE; van der Graaf Y; Cook NR
    Heart; 2015 Mar; 101(5):369-76. PubMed ID: 25475110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
    Baigent C; Collins R; Appleby P; Parish S; Sleight P; Peto R
    BMJ; 1998 May; 316(7141):1337-43. PubMed ID: 9563981
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 47.